Business & regional news

May 4, 2024

SCAI 2024: Medtronic transcatheter therapies show excellent outcomes in the treatment of congenital heart disease and severe aortic stenosis

Medtronic, the global leader in healthcare technology, today announced the release of important clinical outcomes in two leading transcatheter valve therapies. The results for these studies were...
- Structural Heart and Aortic
Apr 30, 2024

CRISTAL study published in The Lancet Diabetes & Endocrinology shows promising outcomes for pregnant women living with type 1 diabetes

Study shows the investigational use of the MiniMed™ 780G system improved glycemic control during pregnancy. Medtronic, a global leader in healthcare technology, today announced the results of...
- Diabetes
Apr 29, 2024

April 29 proclaimed ‘Medtronic Day’ in Minnesota

Honorary day celebrates Medtronic roots, 75th anniversary year
- Photos 6
Apr 24, 2024

New randomized controlled data from VenaSeal Spectrum Program reinforces evidence that VenaSeal™ closure system is safe and effective
- Peripheral Vascular Health
Apr 23, 2024

Medtronic welcomes compelling evidence from Europe and Asia that reveal advanced hybrid closed loop systems are more cost-effective than standard management of type 1 diabetes

Groundbreaking studies in Europe and Singapore demonstrate the Medtronic MiniMed™ 780G system can generate cost-savings for health systems. Medtronic, a global leader in healthcare technology,...
- Diabetes

Show per page